Clinical Trials Logo

Clinical Trial Summary

Acute Aortic Syndrome (AAS) is a common feature of acute aortic wall events, including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35 cases per 100,000 cases per year between the ages of 65 and 75 years. Ulinastatin has antiinflammatory activity and suppresses the infiltration of neutrophils and the release of elastase and chemical mediators from neutrophils. Recent studies have shown that ulinastatin may be cytoprotective against ischemia-reperfusion injury in the liver, kidney, heart, and lung. The authors aim to examine the association between decreased release of inflammatory response to urinary trypsin inhibitor treatment and decreased myocardial and lung injury after acute aortic syndrome surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04711889
Study type Interventional
Source Nanjing Medical University
Contact
Status Completed
Phase N/A
Start date January 1, 2021
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT03647566 - 18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
Recruiting NCT05965453 - Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
Recruiting NCT05339529 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V N/A
Recruiting NCT06277895 - VOCs in Patients With Acute Cardiogenic Chest Pain N/A
Completed NCT02273245 - Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome? N/A
Recruiting NCT04699279 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Rosuvastatin) I N/A
Enrolling by invitation NCT04398992 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
Completed NCT04751058 - Genetic Profile in Patients With Aortic Syndrome
Completed NCT04430400 - Integrated Diagnostic Algorithm for Acute Aortic Syndromes
Completed NCT01259843 - French National Observatory of Aortic Syndromes